Zealand Pharma A/S
OTC: ZLDPF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Adam Sinding Steensberg
- Employees
- 385
- Headquarters
- Copenhagen, Denmark
- IPO year
- 2013
- Market cap
- $3.0B
- Website
- https://www.zealandpharma.com
Loading ZLDPF…
Loading profile data…Frequently asked questions about ZLDPF
What does Zealand Pharma A/S (ZLDPF) do?
Based in Copenhagen, Denmark, Zealand Pharma A/S operates as a biotechnology company dedicated to the entire lifecycle of peptide-based medicines – from their initial discovery and development through to their ultimate commercialization. Its therapeutic portfolio primarily targets gastrointestinal and metabolic disorders, alongside other special...
Where does ZLDPF trade?
Zealand Pharma A/S (ZLDPF) trades on the Other OTC.
What sector is ZLDPF in?
Zealand Pharma A/S (ZLDPF) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Zealand Pharma A/S?
Adam Sinding Steensberg is the chief executive officer of Zealand Pharma A/S (ZLDPF).
Where is Zealand Pharma A/S headquartered?
Zealand Pharma A/S is headquartered in Denmark.
Does ZLDPF pay a dividend?
Zealand Pharma A/S (ZLDPF) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ZLDPF go public?
Zealand Pharma A/S (ZLDPF) completed its initial public offering in 2013.